• 1
    Merrill RM. Hysterectomy surveillance in the United States, 1997 through 2005. Med Sci Monit. 2008;14:CR24-CR31.
  • 2
    Merrill RM. Impact of hysterectomy and bilateral oophorectomy on race-specific rates of corpus, cervical, and ovarian cancers in the United States. Ann Epidemiol. 2006;16:880-887.
  • 3
    Jemal A, Simard EP, Dorell C, et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013;105:175-201.
  • 4
    Surveillance, Epidemiology, and End Results (SEER) Program ( SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2011 Sub(1973-2009 varying)-Linked to County Attributes - Total U.S., 1969-2010 Counties. Surveillance, Epidemiology, and End Results (SEER) Program, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2012, based on the November 2011 submission. Accessed February 22, 2013.
  • 5
    Behavioral Risk Factor Surveillance System Survey Data 2000, 2002, 2004, 2006, 2008, 2010: US Department of Health and Human Services, Centers for Disease Control and Prevention. Accessed February 22, 2013.
  • 6
    Selvin S. Statistical Analysis of Epidemiologic Data. 3rd ed. New York, NY: Oxford University Press; 2004.
  • 7
    Simard EP, Ward EM, Siegel R, Jemal A. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin. 2012;62:118-128.
  • 8
    National Cancer Institute. Surveillance Research. Joinpoint Regression Program. Accessed February 22, 2013.
  • 9
    Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335-351.
  • 10
    Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012;62:147-172.
  • 11
    Kulasingam SL, Havrilesky L, Ghebre R, Myers ER. Screening for Cervical Cancer: A Decision Analysis for the U.S. Preventive Services Task Force. Evidence Syntheses, No. 86s. Rockville, MD: Agency for Healthcare Research and Quality; 2011.
  • 12
    Kamineni A, Weinmann S, Shy KK, Glass AG, Weiss NS. Efficacy of screening in preventing cervical cancer among older women. Cancer Causes Control. 2013;24:1653-1660.
  • 13
    Pettersson BF, Hellman K, Vaziri R, Andersson S, Hellstrom AC. Cervical cancer in the screening era: who fell victim in spite of successful screening programs? J Gynecol Oncol. 2011;22:76-82.
  • 14
    Rebolj M, van Ballegooijen M, Lynge E, et al. Incidence of cervical cancer after several negative smear results by age 50: prospective observational study. BMJ. 2009;338:b1354.
  • 15
    World Health Organization. WHO/ICO HPV Information Centre. Human Papillomavirus and Related Cancers in World. Summary Report 2009. Accessed June 19, 2013.
  • 16
    World Health Organization. WHO/ICO HPV Information Centre. Human Papillomavirus and Related Cancers in Americas. Summary Report 2009. Accessed June 19, 2013.
  • 17
    Simard EP, Naishadham D, Saslow D, Jemal A. Age-specific trends in black-white disparities in cervical cancer incidence in the United States: 1975-2009. Gynecol Oncol. 2012;127:611-615.
  • 18
    DeSantis C, Naishadham D, Jemal A. Cancer statistics for African Americans, 2013. CA Cancer J Clin. 2013;63:155-166.
  • 19
    Laz TH, Rahman M, Berenson AB. Human papillomavirus vaccine uptake among 18- to 26-year-old women in the United States: National Health Interview Survey, 2010. Cancer. 2013;119:1386-1392.